The generation of bioactive molecules from inactive precursors is ac rucial step in the chemical evolution of life, however,mechanistic insights into this aspect of abiogenesis are scarce.Here,weinvestigate the protein-catalyzed formation of antivirals by the 3C-protease of enterovirusD 68. The enzyme induces aldol condensations yielding inhibitors with antiviral activity in cells.K inetic and thermodynamic analyses reveal that the bioactivity emerges from ad ynamic reaction system including inhibitor formation, alkylation of the protein target by the inhibitors,a nd competitive addition of non-protein nucleophiles to the inhibitors.T he most active antivirals are slowlyr eversible inhibitors with elongated target residence times.T he study reveals first examples for the chemical evolution of bio-actives through protein-catalyzed, non-enzymatic CÀCcouplings.The discoveredmechanism works under physiological conditions and might constitute anative process of drug development.
SARS coronavirus main proteases (3CL proteases) have been validated as pharmacological targets for the treatment of coronavirus infections. Current inhibitors of SARS main protease, including the clinically admitted drug nirmatrelvir are peptidomimetics with the downsides of this class of drugs including limited oral bioavailability, cellular permeability, and rapid metabolic degradation. Here, we investigate covalent fragment inhibitors of SARS Mpro as potential alternatives to peptidomimetic inhibitors in use today. Starting from inhibitors acylating the enzyme's active site, a set of reactive fragments was synthesized, and the inhibitory potency was correlated with the chemical stability of the inhibitors and the kinetic stability of the covalent enzyme‐inhibitor complex. We found that all tested acylating carboxylates, several of them published prominently, were hydrolyzed in assay buffer and the inhibitory acyl‐enzyme complexes were rapidly degraded leading to the irreversible inactivation of these drugs. Acylating carbonates were found to be more stable than acylating carboxylates, however, were inactive in infected cells. Finally, reversibly covalent fragments were investigated as chemically stable SARS CoV‐2 inhibitors. Best was a pyridine‐aldehyde fragment with an IC50 of 1.8 μM at a molecular weight of 211 g/mol, showing that pyridine fragments indeed are able to block the active site of SARS‐CoV‐2 main protease.
Pneumolysin (PLY) is a pore-forming, cholesterol-dependent cytolysin (CDC) from Streptococcus pneumoniae, the main bacterial cause for community-acquired pneumonia. Liberation of PLY during host infection leads to strong immune activation and cytolytic cell death. Thus, inhibition of PLY could be a valuable approach to attenuate detrimental effects of hyper-inflammatory immune reactions during pneumococcal lung infection. Here, we report discovery, development, and validation of small molecule inhibitors of PLY, denominated as pore-blockers (PB). PB-1 was identified by combined screening inhibiting PLY-mediated hemolysis. PB-2 blocked pore formation with greatly improved potency as demonstrated by cryo-electron tomography. Scaffold-hopping delivered PB-3 with superior chemical stability, solubility, and a specific mode of action, characterized by an elongated residence time. It prevented human lung epithelial cells from PLY-mediated cytolysis and cell death, also during infection with Streptococcus pneumoniae. In conclusion, druglike PLY-inhibitors such as PB-3 might become valuable adjuvant options in the treatment of severe pneumococcal infections.
This is a case report of A 27 years old female was brought to the emergency department with the complaint
of progressive abdominal distension with pain in abdomen and early satiety for last few months. On
further clinical, radiological and laboratory evaluation, patient was diagnosed with portal hypertension with splenomegaly and
got collapsed during the course of treatment. On autopsy examination, the cause of death was hemorrhagic shock due to rupture
of esophageal varices.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.